Skip to content

Journal of Analytical Toxicology

ISSN 0146-4760, 1945-2403

57 papers in the library · 1,574 citations · publishing 1977-2026

Papers

Sort Most recent Most cited

Pharmacokinetic study of delta-8-tetrahydrocannabinol in male rats using a validated bioanalytical method.

Journal of Analytical Toxicology April 30, 2026 Alexandria S. Senetra, Sushobhan Mukhopadhyay, Yi-Hua Chiang et al.

Delta-8-tetrahydrocannabinol (Δ8THC) has been growing in popularity across the United States due to its reported therapeutic benefits, including pain relief, euphoria, relaxation, and mild psychoactive effects, especially in areas where sale of delta-9-tetrahydrocannabinol (Δ9THC) is illegal. Currently, much debate surrounds Δ8THC regarding its regulatory status and whether this compound is...

Psilocin glucuronide in whole blood: a stable and useful biomarker of psilocybin intake

Journal of Analytical Toxicology February 19, 2026 Marianne Skov-Skov Bergh, Inger Lise Bogen, Merete Vevelstad et al.

Detecting psilocybin use is challenging because it rapidly converts to its psychoactive metabolite psilocin, and both compounds are unstable in blood. Bufotenin, a structural isomer of psilocin, may exhibit comparable instability in blood. For reliable detection, we developed and validated an LC-MS/MS method to simultaneously quantify psilocin, bufotenin, and their metabolites, psilocin...

DOI: 10.1093/jat/bkag015 (opens in new tab) Psilocybin Metabolite Analyte Protein precipitation +10

Fatalities following DMT use: Two case reports and a review of the literature.

Journal of Analytical Toxicology July 9, 2025 Jade Pullen, Robert J. Moore, Rebecca Wood et al. 1 citation

N, N-dimethyltryptamine (DMT) is a hallucinogen found in the South American Psychotria viridis plant and is the major psychoactive ingredient in the brew ayahuasca. In this report we performed a review of the surrounding literature and detail two deaths which recently occurred in the UK following DMT use. A literature search of both academic (PubMed, GoogleScholar) and media (using Google...

Driving under the influence of cocaine and MDMA: Relationship between blood concentrations and results from clinical test of impairment.

Journal of Analytical Toxicology June 11, 2024 Gunhild Heide, Ragnhild Elén Gjulem Jamt, Jonas Fainberg-Sandbu et al. 8 citations

The general use of cocaine is increasing in recent years, while the trend for 3,4-methylenedioxymethamphetamine (MDMA) is less clear. The relationship between blood concentrations and impairment is poorly understood, which complicates interpretation. The aims of this study were to report prevalence and blood concentrations of cocaine and MDMA in drugged drivers, and to investigate the...

DOI: 10.1093/jat/bkae024 (opens in new tab) Full text (opens in new tab) MDMA Drug testing Impaired driving Traffic safety +1

2-Fluorodeschloroketamine consumption: About two deaths and a case of self-mutilation.

Journal of Analytical Toxicology June 11, 2024 Salomé Riess, Marjorie Chèze, Aurelie Muckensturm et al. 5 citations

2-Fluorodeschloroketamine (2-FDCK) is a new psychoactive substance (NPS), close to the ketamine structure. Few cases of 2-FDCK intake are described in the forensic literature, especially concerning death cases. We report here a case of self-mutilation (Case 1) and two forensic deaths linked to 2-FDCK consumption. The second case involved a man found dead in the street, having been stabbed. The...

DOI: 10.1093/jat/bkae021 (opens in new tab) Full text (opens in new tab) Drug toxicology Novel psychoactive substances Ketamine analogs Forensic chemistry +1

In vitro and in vivo metabolic study of three new psychoactive β-keto-arylcyclohexylamines.

Journal of Analytical Toxicology May 20, 2024 Linhao Xu, Hui Yan, Yiling Tang et al. 3 citations

Since the 2000s, an increasing number of new psychoactive substances have appeared on the illicit drug market. β-Keto-arylcyclohexylamine compounds play important pharmacological roles in anesthesia; however, because these new psychoactive substances have rapidly increasing illicit recreational use, the lack of detailed toxicity data are of particular concern. Therefore, analysis of their...

DOI: 10.1093/jat/bkae020 (opens in new tab) Full text (opens in new tab) Forensic toxicology Novel psychoactive substances Legal highs Club drugs +3

Fatal Intoxications from a Combination of 4-Fluoroamphetamine and 25C-NBOMe.

Journal of Analytical Toxicology March 21, 2023 Dimitri Gerostamoulos, Linda Glowacki, Maria Pricone et al. 9 citations

Six fatalities have occurred from the ingestion of a combination of new psychoactive substances (NPSs), 4-fluoroamphetamine (4FA) and 2-(4-chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25C-NBOMe) over a 9-month period. Four of these fatalities (one older female and three young males) were from direct adverse effects of drugs, and one each from a fall while being intoxicated...

A Fatal Case Report Resulting from the Abuse of the Designer Benzodiazepines Clonazolam and Flualprazolam in Conjunction with Dried Opium Poppy Pods

Journal of Analytical Toxicology November 1, 2022 Nadine Theofel, Philipp Möller, Elke Vejmelka et al. 10 citations

Toxicologists are often confronted with the abuse of multiple drugs and are obliged to decide which compound may have been the cause of death. We report on a 21-year-old man (182 cm, 84 kg), who was found unconscious in his bed. Beside him, the police found several controlled substances, among them were dried opium poppy pods containing thebaine, codeine and morphine, a clear liquid with the...

DOI: 10.1093/jat/bkac098 (opens in new tab) Thebaine Codeine Chromatography Designer drug +5

Loss of Consciousness and Visual Hallucinations Related to 5-MeO-DALT Intake, a Case Report Confirmed by Toxicological Analyses.

Journal of Analytical Toxicology August 13, 2022 Laurène Dufayet, Jérôme Langrand, Jean-Claude Alvarez et al. 3 citations

5-MeO-DALT or 5-methoxy-N,N-diallyltryptamine is a derivative of tryptamines, consumed for its hallucinogenic and entheogenic effects. We report the case of a 46-year-old-man, presenting with a brief loss of consciousness and visual hallucinations, after the consumption of three 5-MeO-DALT tablets bought online. Liquid chromatography coupled to tandem mass spectrometry method was performed, and...

The First Fatal Intoxication with 3-MeO-PCP in the UK and a Review of the Literature.

Journal of Analytical Toxicology May 20, 2022 Caroline S Copeland, Simon Hudson, Ric Treble et al. 9 citations

The phencyclidine derivative 3-methoxyphencyclidine (3-MeO-PCP) is a potent dissociative hallucinogen. Sought for recreational use as a novel psychoactive substance, it can also induce acute psychological agitation and pathophysiological cardiorespiratory effects. Due to the harms associated with its use, 3-MeO-PCP was added to the "Green List" of materials covered by the 1971 Convention on...

Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2017–2020: A Review

Journal of Analytical Toxicology April 20, 2022 Amanda L A Mohr, Barry K. Logan, Melissa F. Fogarty et al. 66 citations

An important role of modern forensic and clinical toxicologists is to monitor the adverse events of novel psychoactive substances (NPS). Following a prior review from 2013 to 2016, this critical literature review analyzes and evaluates published case reports for NPS from January 2017 through December 2020. The primary objective of this study is to assist in the assessment and interpretation of...

DOI: 10.1093/jat/bkac023 (opens in new tab) Full text (opens in new tab) Synthetic cannabinoids Adverse effect Polypharmacy Hallucinogen +4

Increasing Prevalence of Ketamine in Drivers in New York City Including the Identification of 2-Fluoro-Deschloroketamine.

Journal of Analytical Toxicology September 17, 2021 Elba Arango, Allison Toriello, Zoila Rosario et al. 17 citations

Ketamine is a dissociative anesthetic used in veterinary and human medicine since the 1970s. Its clinical use has expanded to control of seizures, by pre-hospital emergency medical services (EMS), and is finding new purpose as an analgesic alternative and antidepressant. Ketamine brings hope for effective management of chronic pain in the absence of opioids and decreasing suicidal ideations;...

Can the Intake of a Synthetic Tryptamine be Detected Only by Blood Plasma Analysis? A Clinical Toxicology Case Involving 4-HO-MET

Journal of Analytical Toxicology June 3, 2021 Lea Wagmann, Sascha K. Manier, Markus R Meyer 11 citations

Tryptamines represent a group of hallucinogenic new psychoactive substances with increasing prevalence. Unfortunately, only limited data concerning their toxicology and bioanalysis are available as tryptamines are not included in routine screening procedures in many laboratories. In order to expand the current knowledge, we report a non-fatal clinical toxicology case involving the synthetic...

DOI: 10.1093/jat/bkab062 (opens in new tab) Tryptamines Forensic toxicology Synthetic cannabinoids Clinical toxicology +3

2-(4-Iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOME): A Harmful Hallucinogen Review.

Journal of Analytical Toxicology January 21, 2021 Katarzyna Kamińska, Paweł Świt, Kamilla Malek 9 citations

NBOMes are N-benzylmethoxy derivatives of the 2C family compounds with N-2-methoxybenzyl moiety substituted by the methoxy group at the 2- and 5-position and the halogen group at the 4-position of the phenyl ring. These substances are a new class of potent serotonin 5-HT2A receptor agonist hallucinogens with potential harmful effects. The substitution with halogen of the already psychoactive...

DOI: 10.1093/jat/bkaa022 (opens in new tab) Full text (opens in new tab) 25i-nbome 25i-nbome Synthetic hallucinogen Designer drug Novel psychoactive substance +19

Severe Neurological Sequelae after a Recreational Dose of LSD

Journal of Analytical Toxicology October 2, 2020 Rachel Aakerøy, Wenche Rødseth Brede, Stian Bergseng Stølen et al. 9 citations

Abstract A young man with an unremarkable medical history suffered a seizure with subsequent cardiorespiratory arrest and severe neurological sequelae after ingesting a blotter. Analysis of a similar blotter and a serum sample obtained 3 h after the event detected lysergic acid diethylamide (LSD) at an amount of 300 µg in the blotter and at a concentration of 4.0 ng/mL (12.4 nmol/L) in the...

DOI: 10.1093/jat/bkaa145 (opens in new tab) Full text (opens in new tab) Lysergic acid diethylamide Cardiorespiratory fitness Adverse effect Recreational use +5

A Fatal Case Involving N-Ethyldeschloroketamine (2-Oxo-PCE) and Venlafaxine.

Journal of Analytical Toxicology October 26, 2018 Nadine Theofel, P. Möller, Elke Vejmelka et al.

Methoxetamine, 3-methoxyphencyclidine or 3-methoxyeticyclidine are arylcyclohexylamines which have been abused in the past. However, the market for new psychoactive substances, in particular for research chemicals, is rapidly growing and new compounds are being regularly explored by users. Abuse can lead to clinical case and in the worst-case scenario to fatalities. We present the fatal case of...

Two Fatal Intoxications Involving 3-Methoxyphencyclidine.

Journal of Analytical Toxicology July 1, 2017 Christie Mitchell-Mata, Brittany Thomas, Brianna L Peterson et al.

3- and 4-methoxyphencyclidine (3-MeO-PCP, 4-MeO-PCP), structural analogs of phencyclidine (PCP), were among the first legal PCP alternatives to show up on the novel psychoactive substances (NPS) market in Europe in the 2000s. Their structural similarities to PCP and ketamine likely contribute to their demonstrated dissociative anesthetic effects. Limited information exists in the literature...

Two Cases of Non-fatal Intoxication with a Novel Street Hallucinogen: 3-Methoxy-Phencyclidine.

Journal of Analytical Toxicology May 1, 2017 Monika Židková, Tomáš Hložek, Martin Balik et al.

3-Methoxy-phencyclidine (3-MeO-PCP) is a structural derivative of the dissociative hallucinogen phencyclidine (PCP). Although PCP toxicity is well documented, little is known about this new psychoactive substance despite being available on the black market even in central Europe. The objective of this case report is to present clinical and laboratory data of analytically confirmed non-fatal...

Mistaking 2C-P for 2C-B: What a Difference a Letter Makes.

Journal of Analytical Toxicology 2017 Adrian Stoller, Patrick C. Dolder, Michael Bodmer et al. 19 citations

2,5-Dimethoxy-4(n)-propylphenethylamine (2C-P) is a synthetic phenethylamine derivative belonging to the large family of the so-called 2C drugs. These compounds can differ significantly in receptor affinity, potency and duration of action, and an important structural difference is the ligand in the 4 position of the phenyl ring, such as propyl in 2C-P or bromine in...

DOI: 10.1093/jat/bkw108 (opens in new tab) Full text (opens in new tab) Chemical structure variation Drug potency Synthetic drugs Adverse drug effects

An Impaired Driver Found to be Under the Influence of Methoxetamine.

Journal of Analytical Toxicology October 1, 2016 Timothy C Fassette, Afton Martinez

The popularity of designer drugs has increased over the past few years as users seek new, cheap and sometimes "legal" ways to get high. This case report focuses on a case that happened in the City of Henderson, Nevada, which involved the designer drug methoxetamine. Methoxetamine is a psychoactive compound that is structurally related to ketamine and reported to have similar effects. These...

Fatal Intoxication Involving 3-MeO-PCP: A Case Report and Validated Method.

Journal of Analytical Toxicology September 1, 2016 Erica L. Bakota, Crystal Arndt, A. Romoser et al.

We present in this case report a validated method for accurate quantitative analysis of 3-methoxy phencyclidine (3-MeO-PCP) to determine postmortem blood concentrations of this PCP analog. A 29-year-old male with a history of illicit drug use was found unresponsive in his bed with a bag of white powder next to him. Resuscitation efforts were unsuccessful and the individual was pronounced dead 9...

A Case Review of the First Analytically Confirmed 25I-NBOMe-Related Death in Washington State.

Journal of Analytical Toxicology October 1, 2015 L. M. Lowe, Brianna L Peterson, Fiona J. Couper

This case was submitted to the Washington State Patrol Toxicology Laboratory in September 2014. A 15-year-old male went to a party where he ingested 25I-NBOMe and mushrooms. A short time later, he started to vomit and began seizing until he eventually passed out. Resuscitation efforts were made, but were unsuccessful. He was transported to a local hospital, where he died three days later of...

Fatal Intoxications with 25B-NBOMe and 25I-NBOMe in Indiana During 2014.

Journal of Analytical Toxicology October 1, 2015 Kevin G Shanks, Thomas J. Sozio, George S Behonick

Over the last few years, NBOMe substances have been used either as a legal alternative to lysergic acid diethylamide (LSD) or sold surreptitiously as LSD to unknown users. These NBOMe substances have been detected in blotter papers, powders, capsules and liquids. We report the deaths of two teenage male subjects that were related to 25B-NBOMe and 25I-NBOMe in Indiana during 2014. Samples were...

A Fatality Related to Two Novel Hallucinogenic Compounds: 4-Methoxyphencyclidine and 4-Hydroxy-N-methyl-N-ethyltryptamine

Journal of Analytical Toxicology August 10, 2015 Iain M. Mcintyre, Amber Trochta, Ray D. Gary et al. 30 citations

In this case report, we present an evaluation of postmortem concentration distribution of the hallucinogenic compound 4-methoxyphencyclidine (4-MeO-PCP) in a fatality principally attributed to this drug. Another hallucinogen, 4-hydroxy-N-methyl-N-ethyltryptamine was also detected, but was not quantitated. A man--who had a history of recent 'strange' behavior--was found deceased, on his bed, in...

Smoked Cannabis' Psychomotor and Neurocognitive Effects in Occasional and Frequent Smokers

Journal of Analytical Toxicology March 4, 2015 Nathalie A. Desrosiers, Johannes G. Ramaekers, Émeline Chauchard et al. 136 citations

Δ9-Tetrahydrocannabinol (THC), the primary psychoactive constituent in cannabis, impairs psychomotor performance, cognition and driving ability; thus, driving under the influence of cannabis is a public safety concern. We documented cannabis' psychomotor, neurocognitive, subjective and physiological effects in occasional and frequent smokers to investigate potential differences between these...

DOI: 10.1093/jat/bkv012 (opens in new tab) Full text (opens in new tab) Cannabis Psychomotor learning Neurocognitive Cognition +4